Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex

(−)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells

(2010) Christine A. Larsen et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

EGFR Signaling and Drug Discovery

(2010) Georg Lurje et al.   ONCOLOGY

Cellular Proliferation, Apoptosis and Angiogenesis: Molecular Targets for Nutritional Preemption of Cancer

(2010) Cindy D. Davis et al.   SEMINARS IN ONCOLOGY

Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression

(2009) Xi Wang et al.   ARCHIVES OF PHARMACAL RESEARCH

The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non-small Cell Lung Cancer Cells

(2009) S. A. Milligan et al.   CLINICAL CANCER RESEARCH

Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects

(2009) Jorg Hartmann et al.   CURRENT DRUG METABOLISM

Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets

(2009) Jeffrey A Knauf et al.   CURRENT OPINION IN CELL BIOLOGY

Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer

(2007) Libero Santarpia et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM